420 likes | 656 Views
Nano-Sized Drug Delivery. Prof. Heather D. Maynard Department of Chemistry and Biochemistry University of California, Los Angeles. Topic of Today’s Lecture. This talk will focus on my research on combining synthetic polymers with proteins from Nature to produce nano-sized medicines.
E N D
Nano-Sized Drug Delivery Prof. Heather D. Maynard Department of Chemistry and Biochemistry University of California, Los Angeles
Topic of Today’s Lecture This talk will focus on my research on combining synthetic polymers with proteins from Nature to produce nano-sized medicines
Outline of Today’s Lecture • What is nano? • Polymers are everywhere! • Why nanosized carriers are important in medicine • Protein-polymer nano-therapeutics
Outline of Today’s Lecture • What is nano? • Polymers are everywhere! • Why nanosized carriers are important in medicine • Protein-polymer nano-therapeutics
What is Nano? • Nanoscience is the study of objects measured in nanometers • 1-billionth of a meter • ~80,000 times smaller than the diameter of a single human hair
Closer Look at a Human Hair Width of this line is 100 nm http://www.aber.ac.uk/bioimage/image/uwbl-0411-w.jpg
What is Nano? • Nanoscience is the study of objects measured in nanometers • 1-billionth of a meter • ~80,000 times smaller than the diameter of a single human hair • New properties emerge at the nanoscale • Size and shape matter
Super-Repellent Nano-Materials http://cjmems.seas.ucla.edu/members/changhwan/main.html http://www.engineer.ucla.edu/magazine/fall06/noslip.html
Nano-Finger Tips Allow Geckos to Stick http://robotics.eecs.berkeley.edu/~ronf/Gecko/index.html
Super Adhesive Nano-Materials Synthetic nano-materials can exhibit strong adhesion similar to gecko fingers Yurdumarkan et al, Chem. Commun. 2005, 3799-3801
How Nano Effects You Nanotech products are already on the market
According to the National Nanotechnology Initiative (NNI), “The worldwide workforce necessary to support the field of nanotechnology is estimated at 2 million by 2015”* UCLA is at the forefrontof nanotechnology research and education!! There are many course that are now offered on the subject, including my BioNanotechnology Course (Chem140/240) *http://www.nano.gov/html/edu/home_edu.html
Outline of Today’s Lecture • What is nano? • Polymers are everywhere! • Why nanosized carriers are important in medicine • Protein-polymer nano-therapeutics
“I just want to say one word to you – just one word…. plastics.”The Graduate (1967)
Polymers • Big molecules made of repeating units of smaller molecules • Small molecules are called “monomers” • Monomers link together like a chain • Results in new and exciting properties!!
Polymers – Everywhere in Daily Life DNA Starch Cellulose Rubber HDPE Teflon Nylon PVC
Data from 2004 showed that plastics industry including suppliers accounted for 2.1 million jobs and $438 billion in shipments* It is estimated that half of all industrial chemists work in some area of polymer chemistry** Therefore it is vital that chemistry students learn about polymers. At UCLA we teach the chemical aspects of polymers in a devoted course (Chem 181), as well as in the Sophomore Organic Chemistry Series (Chem 30C) * http://www.gcx-online.com/gcx/article.asp?magarticle_id=561 **Zumdahl, S. S. Chemical Principles; D. C. Heath and Co.’ Lexington, Massachusetts, 1992, p. 947
Different Shapes and Sizes The way the monomers are connected has a very large influence on the resultant properties Duncan Nature Reviews2003, 2, 347-360
Transdermal Patch Microspheres Biodegradable Polymer Drug: Fentanyl (pain killer) Nicotine Name: Duragesic, Nicoderm, Habitrol, Prostep, Nicotrol Dosis: 72 hours (fentanyl) Biodegradable Polymer Drug: luteinizing hormone-releasing hormone (LHRH) analog Name: Decapeptyl, Lypron depot Advanced prostate cancer Dose: ~3 months Polymers in Medicine Moses, M.; Brem, H.; Langer, R. Cancer Cell, 2003, 4, 337
Outline of Today’s Lecture • What is nano? • Polymers are everywhere! • Why nanosized carriers are important in medicine • Protein-polymer nano-therapeutics
Nano in Medicine • A nano sized “pill” • They target tumors to deliver cancer drugs • Nano “pills” can be modified to hone to a other tissues in the body to deliver drugs for other diseases
Tumors Grow Blood Vessels Tumors need blood to grow larger than ~2mm in size Peer, D, et al. Nature Nanotechnology 2007, 2, 751-760
EPR Effect • Tumors have “leaky” blood vessels, which allow relatively large nano-sized “pills” to enter. This is called Enhanced Permeability and Retention (EPR) Effect . Normal blood vessels are not “leaky” and nano-particles are prevented from entering. This allows one to selectively target tumors. Duncan, R. Nature Reviews Cancer 2006, 6, 688-701
Polymers Form Nano “Pills” Duncan Nature Reviews2003, 2, 347-360
Nano Carriers Example: AmBisome Drug: amphotericin B antifungal infections for cancer patients Name of product: AmBisome Approved in 1997 Moses, M.; Brem, H.; Langer, R. Cancer Cell, 2003, 4, 337
Nano Carriers Example: Doxil Drug: doxorubicin Chemotherapy agent for ovarian cancer Name of product: Doxcil Reduced cardiotoxicity Http://www.doxil.com
Nano Carriers Example: Abraxane Drug: Paclitaxel Chemotherapy for breast cancer Name of product: Abraxane Approved in 2005 ($134 million in sales that year)* Chemotherapeutic bound to protein nano-particle Http://www.abraxisbio.com *Data from Small Times
Outline of Today’s Lecture • What is nano? • Polymers are everywhere! • Why nanosized carriers are important in medicine • Protein-polymer nano-therapeutics
What is a Protein? Proteins are natural polymers found in the body that are made up of many small units that are called amino acids. Protein comes from Greek word proteios meaning primary Proteins are critical to life and serve many different functions Structure of protein called myoglobin which delivers oxygen to muscle tissues http://en.wikipedia.org/wiki/Protein
Protein Function Proteins regulate the function and structure of cells, tissues and organs Examples Hemoglobin carries oxygen through the body. Melaningives skin pigmentation and the iris color. Keratin provides structure of hair and nails. Serum Albuminmaintains blood pressure. Alcohol Dehydrogenasebreaks down alcohol in the liver.
Commercial Protein Therapeutics Proteins are highly evolved and specific, so they make excellent drugs • Insulin • Helps to regulate blood glucose levels for people with diabetes. • Interferon-a(Intron A, Roferon) • Used for the treatment of chronic hepatitis C in adults. • Erythropoietin (Procrit, Epogen) • Used to treat anemia caused by chemotherapy, HIV or kidney disease. • Glycoprotein which stimulates the production of red blood cells.
Proteins Degrade Proteins must be injected – they are not taken orally Proteins rapidly degrade in the body by natural mechanisms This means that in order to have a sustained affect – the patient must endure many injections
One Solution By attaching polymer chains, the protein is protected from degradation, circulates longer in the blood stream, has a decreased immune response, and lasts longer in the body This means fewer injections for the patient and better compliance
Advantages of Protein-Polymer Conjugates Protein-polymer therapeutics are nano-sized drugs with many advantages Francesco M. Veronese et al., Drug Discovery Today2005, 10, 1451-1458
PEG – a Special Polymer polyethylene glycol or polyethylene oxide or PEG or PEO • FDA approved • Protein resistant • Water soluble • Low immune response • Biocompatible
Protein-Polymer Conjugates Interferon a Attaching polymers to proteins is called “PEGylation”: Interferon a + Polyethylene glycol PEG Intron A PEG Intron requires only 1 injection per week, compared to three injections per week of Intron A Data from the FDA
Protein-Polymer Conjugates on Market Many of these nano-drugs are clinically used www.debio.com/e/pdf/peg_e.pdf Duncan Nature Reviews Cancer, 2006
Maynard Group Research My group focuses on developing new synthetic methods to generate this important class of materials, such that the resulting protein-polymer conjugates have superior properties Heredia & Maynard, OBC, 2007